Clinical Trial Update: Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells [NA]

View source ↗

Summary

A clinical trial is evaluating the safety and feasibility of endoscopic duodenal injections of autologous mesenchymal stem cells in adults with type 2 diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Diabete Type 2, Insulin Resistant Diabetes (Mellitus) | NA | Status: NOT_YET_RECRUITING